These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16178910)

  • 41. Treatment concepts of acute promyelocytic leukemia.
    Lengfelder E; Saussele S; Weisser A; Büchner T; Hehlmann R
    Crit Rev Oncol Hematol; 2005 Nov; 56(2):261-74. PubMed ID: 16236522
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Difference in causes and prognostic factors of early death between cohorts with de novo and relapsed acute promyelocytic leukemia.
    Zhao H; Zhao Y; Zhang Y; Hou J; Yang H; Cao F; Yang Y; Hou W; Sun J; Jin B; Fu J; Li H; Wang P; Ge F; Zhou J
    Ann Hematol; 2018 Mar; 97(3):409-416. PubMed ID: 29289982
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Different clinical importance of FLT3 internal tandem duplications in AML according to FAB classification: possible existence of distinct leukemogenesis involving monocyte differentiation pathway.
    Koh Y; Park J; Ahn KS; Kim I; Bang SM; Lee JH; Yoon SS; Soon Lee D; Yiul Lee Y; Park S; Kim BK
    Ann Hematol; 2009 Nov; 88(11):1089-97. PubMed ID: 19296110
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acute biphenotypic leukaemia.
    Chim CS; Ma SK
    Haematologica; 2002 Jan; 87(1):EIM03. PubMed ID: 11801484
    [No Abstract]   [Full Text] [Related]  

  • 45. Outcome of hyperleukocytic adult acute myeloid leukaemia: a single-center retrospective study and review of literature.
    Marbello L; Ricci F; Nosari AM; Turrini M; Nador G; Nichelatti M; Tedeschi A; Vismara E; Morra E
    Leuk Res; 2008 Aug; 32(8):1221-7. PubMed ID: 18313749
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Effect of additional chromosome abnormalities on the outcome of newly diagnosed acute promyelocytic leukemia treated with red arsenic sulfide and all trans-retinoic acid plus anthracyclin based protocol].
    Lu J; Jiang H; Jiang Q; Bao L; Lu XJ; Zhang Y; Lin W; Liu YR; Huang XJ; Jiang B
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(32):2254-7. PubMed ID: 19087672
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
    Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
    Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acute myeloid leukemia with pseudo-Chèdiak-Higashi anomaly exhibits a specific immunophenotype with CD2 expression.
    Chang H; Yi QL
    Am J Clin Pathol; 2006 May; 125(5):791-4. PubMed ID: 16707384
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Therapy-related acute promyelocytic leukemia after treatment with radioiodine for thyroid cancer: case report with literature review.
    Grudeva-Popova J; Yaneva M; Zisov K; Ananoshtev N
    J BUON; 2007; 12(1):129-32. PubMed ID: 17436415
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Prognostic factor analysis of 77 old patients with acute myelogenous leukemia].
    Shao B; Gao YR; Wang C; Yan SK; Cai Q; Jiang JL; Yang J; Bai HT; Zhao M; Zhao CX
    Ai Zheng; 2006 Aug; 25(8):1007-12. PubMed ID: 16965684
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characteristics features and factors influencing early death in Acute promyelocytic leukemia; Experience from United Arab Emirates (UAE).
    Hassan IB; Zaabi MRA; Alam A; Hashim MJ; Tallman MS; Kristensen J
    Int J Hematol; 2017 Jul; 106(1):90-98. PubMed ID: 28293819
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Microgranular variant of acute promyelocytic leukemia in children.
    Rovelli A; Biondi A; Cantù Rajnoldi A; Conter V; Giudici G; Jankovic M; Locasciulli A; Rizzari C; Romitti L; Rossi MR
    J Clin Oncol; 1992 Sep; 10(9):1413-8. PubMed ID: 1517784
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Expression and clinical significance of nm23-H1 and MUC-1 in peripheral T-cell lymphoma].
    Huang HQ; Pan ZH; Lin XB; Wang BF; Hou JH; Zhang Y; Wu QL
    Ai Zheng; 2006 Dec; 25(12):1517-23. PubMed ID: 17166378
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hypoxia-simulating agents and selective stimulation of arsenic trioxide-induced growth arrest and cell differentiation in acute promyelocytic leukemic cells.
    Yan H; Peng ZG; Wu YL; Jiang Y; Yu Y; Huang Y; Zhu YS; Zhao Q; Chen GQ
    Haematologica; 2005 Dec; 90(12):1607-16. PubMed ID: 16330433
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Long-term therapeutic outcome of patients with acute promyelocytic leukemia].
    Zhang L; Li R; Li DP; Liu YZ; Xu SC; Hao YS; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2007 Jan; 28(1):15-8. PubMed ID: 17649719
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The value of autofluorescence as a diagnostic feature of acute promyelocytic leukemia.
    Hayden PJ; O'Connell NM; O'Brien DA; O'Rourke P; Lawlor E; Browne PV
    Haematologica; 2006 Mar; 91(3):417-8. PubMed ID: 16531269
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Negative stain for myeloid peroxidase and Sudan black B in acute promyelocytic leukemia (APL) cells: report of two patients with APL variant.
    Cui W; Qing S; Xu Y; Hao Y; Xue Y; He G
    Haematologica; 2002 May; 87(5):ECR16. PubMed ID: 12010679
    [No Abstract]   [Full Text] [Related]  

  • 58. [Study of clinical outcome and analysis of prognosis related factor in children with acute myeloid leukemia].
    Zou Y; Wang H; Chen XJ; Wang SC; Zhang L; Chen YM; Zhu XF
    Zhonghua Xue Ye Xue Za Zhi; 2006 Sep; 27(9):621-5. PubMed ID: 17278430
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Precursor T-lymphoblastic lymphoma as a secondary malignancy in a young patient after successful treatment of acute promyelocytic leukemia.
    Szotkowski T; Jarosova M; Faber E; Hubacek J; Hlusi A; Papajik T; Pikalova Z; Kucerova L; Holzerova M; Budikova M; Buriankova E; Plachy R; Potomkova J; Klusova N; Szotkowska R; Indrak K
    Onkologie; 2009 Sep; 32(8-9):513-5. PubMed ID: 19745598
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acute promyelocytic leukemia after mitoxantrone therapy for multiple sclerosis.
    Ramkumar B; Chadha MK; Barcos M; Sait SN; Heyman MR; Baer MR
    Cancer Genet Cytogenet; 2008 Apr; 182(2):126-9. PubMed ID: 18406875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.